Sarcoma and familial retinoblastoma

Clinical and Experimental Ophthalmology

Volumn 31, Issue 5, 2003, Pages 392-396

  Chen, Celia S ^a   Suthers, Graeme ^a   Carroll, Jacqueline ^b   Rudzki, Zbigniew ^b   Muecke, James ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b Division of Tissue Pathology   (Australia)

Author keywords

Inherited; RBI mutation; Retinoblastoma; Sarcoma; Sporadic

Indexed keywords

ANTINEOPLASTIC AGENT; RETINOBLASTOMA PROTEIN;

ADULT; ANAMNESIS; ARTICLE; BAYES THEOREM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; CRYOTHERAPY; DNA DETERMINATION; DNA SCREENING; ENUCLEATION; FAMILIAL DISEASE; FAMILIAL INCIDENCE; FAMILY HEALTH; FAMILY HISTORY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; HERITABILITY; HISTOPATHOLOGY; HUMAN; MALE; MUTATIONAL ANALYSIS; PROBABILITY; RETINOBLASTOMA; RISK ASSESSMENT; SARCOMA;

ADULT; BAYES THEOREM; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; GENES, RETINOBLASTOMA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; RETINAL NEOPLASMS; RETINOBLASTOMA; SARCOMA;

EID: 0344036967     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-9071.2003.00684.x     Document Type: Article

References (14)

1. Gallie BL, Muncaster M, Cohen BL, Gill RM, Hamel PA, Phillips RA. Retinoblastoma mutations: Initiation versus progression of cancer. In: Novak JF, ed. Osterosarcoma Research Conference 1991 Pittsburgh: Hogrefe and Huber, 1993; 367-73.
2. Dunn JM, Phillips RA, Zhu X, Becker A, Gallie BL. Mutation in the RB1 gene and their effects on transcription. Mol Cell Biol 1989; 9: 4594-604.
3. Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969-80: Incidences, treatment and survival. Br J Ophthalmol 1988; 72: 576-83.
4. Kudson AG. Hereditary cancer: Two hits revisited. J Cancer Res Clin Oncol 1996; 122: 135-40.
5. Jay M, Cowell JK, Kingston JE, Hungerfor J. Demonstration of bias in series of retinoblastoma. Ophthalmic Paediatr Genet 1989; 10: 89-92.
6. Bonaiti-Pellie C, Briard-Guillemot ML. Segregation analysis in hereditary retinoblastoma. Hum Genet 1981; 57: 411-19.
7. Murphree AL, Munier F. Retinoblastoma. In: Ryan SJ, ed. Retina. St Louis: Mosby, 1994; 571-626.
8. Miller SA, Dyke DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215-16.
9. Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998; 11: 1-3.
10. Ashby D, Smith AF. Evidence-based medicine as Bayesian decision-making. Stat Med 2000; 19: 3291-305.
11. South Australian Cancer Registry. Epidemiology of Cancer in South Australia, 1977-1999. Adelaide: South Australian Cancer Registry. Department of Human Services, 2000. Available from: http://www.health.sa.gov.au/pehs/cancer-report2001.htm
12. DerKinderen DJ, Koten JW, Nagelkerke NJD, Tan WE, Beemer FA, Den Otter W. Non-ocular cancer in patients with hereditary retinoblastoma and their relatives. Int J Cancer 1988; 41: 499-504.
13. Sippel KC, Fraioli RE, Smith GD et al. Frequency of somatic and germ-line mosaicism in retinoblastoma: Implications for genetic counseling. Am J Hum Genet 1998; 62: 610-19.
14. Noorani HZ, Khan HN, Gallie BL, Detsky AS. Cost comparison of molecular versus conventional screening of relatives at risk of retinoblastoma. Am J Hum Genet 1996; 59: 301-7.